Figure 5 | British Journal of Cancer

Figure 5

From: Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

Figure 5

Genomic copy number profiles before and after treatment. (A) Tumour H13. (B) Tumour H08. (C) Tumour H10. (D) Tumour H19. Gains and losses of whole chromosomes or chromosome arms are seen after treatment. In many cases, these changes produce a less abnormal profile (see text for details).

Back to article page